Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleProceedings of the 4th International Symposium on Vitamin D and Analogs in Cancer Prevention and Therapy, May 20-21, 2011, Homburg/Saar, GermanyR

Ecological Studies of the UVB–Vitamin D–Cancer Hypothesis

WILLIAM B. GRANT
Anticancer Research January 2012, 32 (1) 223-236;
WILLIAM B. GRANT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wbgrant@infionline.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: This paper reviews ecological studies of the ultraviolet-B (UVB)–vitamin D–cancer hypothesis based on geographical variation of cancer incidence and/or mortality rates. Materials and Methods: The review is based largely on three ecological studies of cancer rates from the United States; one each from Australia, China, France, Japan, and Spain; and eight multicountry, multifactorial studies of cancer incidence rates from more than 100 countries. Results: This review consistently found strong inverse correlations with solar UVB for 15 types of cancer: bladder, breast, cervical, colon, endometrial, esophageal, gastric, lung, ovarian, pancreatic, rectal, renal, and vulvar cancer; and Hodgkin's and non-Hodgkin's lymphoma. Weaker evidence exists for nine other types of cancer: brain, gallbladder, laryngeal, oral/pharyngeal, prostate, and thyroid cancer; leukemia; melanoma; and multiple myeloma. Conclusion: The evidence for the UVB–vitamin D–cancer hypothesis is very strong in general and for many types of cancer in particular.

  • Cancer
  • case-control studies
  • ecological
  • melanoma
  • 25-hydroxyvitamin D
  • ultraviolet-B
  • vitamin D
  • mortality rates
  • review

Ecological studies based on geographical variation of cancer incidence and/or mortality rates have made important contributions to the ultraviolet-B (UVB)–vitamin D–cancer hypothesis. This process began when the hypothesis was first proposed on the basis of viewing the map of colon cancer mortality rates for the U.S. and realizing that the mortality rates were correlated with annual sunlight doses (1). The Garland group proposed that because vitamin D production was the most important physiological effect of sunlight for humans, vitamin D probably provided the mechanism linking sunlight to reduced risk of cancer. Later ecological studies by the Garland group added breast (2) and ovarian (3) cancer to the list. Other groups inversely correlated prostate cancer and non-Hodgkin's lymphoma (NHL) with solar UVB indices (4, 5). The total number of UVB-sensitive types of cancer was increased to 15 in 2002 (6). This study was extended in 2006 by including other cancer risk-modifying factors (7, 8). Other studies have reviewed the status of ecological studies of UVB, vitamin D, and cancer as of the end of 2008 (9, 10).

A related study is that of personal UVB irradiance and risk of cancer. Reviewing the field, Rhee and colleagues (11) found that significant inverse correlations were reported for breast, colon, ovarian, prostate, and rectal cancer as well as NHL.

Another approach is to examine the risk of internal cancer after diagnosis of nonmelanoma skin cancer (NMSC). In fact, the first paper suggesting that sunlight might reduce the risk of cancer used this approach (12). Investigating this approach, several studies found it to be a moderately useful index of solar UVB irradiance primarily in sunnier countries (13-15). However, studies found significant inverse correlations in the Netherlands between diagnosis of NMSC and incidence of colorectal (16) and prostate (17) cancer. Those who developed NMSC in Michigan had higher serum 25-hydroxyvitamin D [25(OH)D] levels at the time of the first visit from those who sought osteoporosis- or low bone-density-related advice from 1997 to 2001 (18).

The UVB–vitamin D–cancer hypothesis has also been studied using observational studies of cancer incidence with respect to serum 25(OH)D levels. Studies found significant inverse correlations for breast and colorectal cancer (19-21). Some reports also exist for other types of cancer, such as esophageal (22), oral/pharyngeal (22), ovarian (23), and pancreatic cancer (22, 24), as well as leukemia (22). However, the Vitamin D Pooling Project found no reduced risk of cancer incidence for seven rare types of cancer (25). The likely reason for failure to find an inverse correlation between prediagnostic serum 25(OH)D level and cancer incidence is the long follow-up times involved, 6.63 years. Two studies reported inverse relations for the first few years of follow-up, followed by a direct correlation (26, 27). A recent paper addressed this problem, showing that the serum 25(OH)D level measured at time of enrollment, loses predictive power with increasing follow-up time for breast cancer (28).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Parameters of studies included in this review.

This review examines the ecological studies of cancer incidence and/or mortality rate with respect to solar UVB indices in order to determine how strong the evidence is for various types of cancer, compared to results from other selected studies, and discusses the lessons learned about the use of ecological studies of solar UVB irradiance and disease outcome.

Materials and Methods

Articles on using the ecological approach to study the UVB–vitamin D–cancer hypothesis were sought through the National Library of Medicine's (www.PubMed.gov), with some additional ones found through Google Scholar (www.scholar.google.com). Search terms included cancer, ecological, ultraviolet, and vitamin D. Representative papers were chosen for inclusion in this review. Those chosen were either single-country studies that carried out analyses for several types of cancer or multicountry studies using more than 100 countries and risk-modifying factors in addition to solar UVB indices.

Three U.S. studies were included in the analysis. Two included additional risk-modifying factors (7, 8); the other used solar UVB, NMSC, and lung cancer mortality rates (Grant, CCC, submitted).

Single-country ecological studies for cancer in Australia, China, France, Japan, and Spain were found. The data from France were incidence and mortality rate data for the 21 continental regions for 1998-2000 (29). The regressions were recalculated with respect to latitude for the present article; they differ slightly from the values reported in (30) because latitude rather than the square of latitude was used.

Table I presents the parameters of the various single-country ecological studies. Most studies used mortality rate data, but three also used incidence rate data. The years of the data ranged from 1950-64/5 to 1998-2002. The UVB indices included latitude, temperature, annual solar radiation, and satellite-determined UVB doses for July or the entire year. The study from Australia used cancer mortality rate data for six states and one territory along with an index highly correlated with latitude: dose of cosmic ray neutrons (31, 40). Most studies included other risk-modifying factors such as alcohol consumption, diet, smoking, and socioeconomic status.

This review also includes nine multicountry studies from the Garland group (41-49). These studies were based on cancer incidence rates in 2002 for 107-175 countries. The UVB indices included latitude, stratospheric ozone, cloud cover, and anthropogenic aerosols. These studies also included other risk-modifying factors such as smoking and dietary factors, as deemed appropriate.

Representative results from other studies were also found through www.PubMed.gov. Studies were chosen to illustrate points being made. Some results agree with the ecological studies, but the discussion also includes some that do not.

Results

Table II summarizes findings regarding U.S. cancer incidence and mortality rates. The types of cancer are ordered by the higher mortality rate for males or females in the U.S. for 1970-94 (50) because as the mortality rate declines, obtaining statistically significant results becomes progressively harder (39). At least one study found a statistically significantly reduced risk for 18 types of cancer: bladder, brain, breast, colon, endometrial, esophageal, gallbladder, gastric, ovarian, pancreatic, prostate, rectal, renal, thyroid, and vulvar cancer; Hodgkin's lymphoma and NHL; and multiple myeloma.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Comparison of ecological studies of cancer incidence and mortality rates, United States.

Table III presents the results for the other single-country studies. At least one study found a statistically significantly reduced risk for 14 types of cancer: brain, breast, colon, endometrial, esophageal, gallbladder, gastric, ovarian, pancreatic, prostate, and rectal cancer; Hodgkin's lymphoma; melanoma; and multiple myeloma.

Tables IV and V give the findings from the multicountry studies. The solar UVB indices (aerosols, cloud cover, and/or UVB) are significantly correlated with five types of cancer for both males and females: bladder, brain, lung, renal cancer and leukemia, and one only for males, pancreatic cancer. According to Bernoulli's principle (p<0.05/n, where n is the number of variables), the results for UVB for females for breast, endometrial, and pancreatic cancer are not statistically significant.

Discussion

Hill's criteria for causality in a biological system can be used to assess the evidence in support of the UVB–vitamin D–cancer hypothesis based on ecological studies. Several of these criteria can be evaluated using ecological studies: strength of association, consistency, biological gradient, accounting for confounding factors, and analogy (53). Those that cannot, include plausibility (mechanisms), temporality, and experimental verification; however, other approaches can be used to assess those criteria. The discussion includes such information when appropriate. The types of cancer are discussed in approximate order of the apparent strength of UVB and vitamin D in reducing risk.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Comparison of ecological studies of cancer incidence and mortality rates, other single countries. For Spain, the UVB factor with the highest r value from Ref. 38 is shown.

Specific Types of Cancer

Those with strong evidence.

Colon cancer: Colon cancer was the first type of cancer for which research identified an inverse correlation between solar UVB dose and mortality rate (1). Many ecological and observational studies have since supported this finding (20, 21). Observational studies indicate increasing serum 25(OH)D levels out to above 100 nmol/l can significantly reduce risk (54).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Summary of multicountry studies—males.

Rectal cancer: The findings for rectal cancer are similar to those for colon cancer, and the two types of cancer are often studied together (20, 21, 54).

Breast cancer: Breast cancer was the second type of cancer for which research identified a beneficial effect of solar UVB (2). Case–control studies have supported the role of vitamin D in reducing risk on the basis of serum 25(OH)D levels at time of diagnosis. However, many nested case–control studies (NCCS) found no inverse correlation of breast cancer incidence with respect to prediagnostic serum 25(OH)D level. As the follow-up period increases, the odds/risk ratio tends closer to unity (28). One study found an inverse correlation with serum 25(OH)D for follow-up times up to 10 years, no correlation for 10-15 years, and then a direct correlation for 15-20 years (26). Breast cancer is a rapidly growing cancer on the basis of seasonal peaks of diagnosis in spring and fall (55), and as follow-up time increases, the serum 25(OH)D level at time of diagnosis becomes progressively less meaningful. With this understanding of why NCCS may not support the UVB–vitamin D–cancer hypothesis for breast cancer, the evidence for a beneficial role of UVB and vitamin D is very strong.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Summary of multicountry studies—females.

Gastric cancer: Inverse correlations with solar UVB were found for all the U.S. ecological studies and all the other single-country studies including France, on the basis of a second set of data for 1993-97 not reported (56). Helicobacter pylori is a declining risk factor for gastric cancer, and some evidence exists that vitamin D strengthens the immune system response to H. pylori infection (57). In addition, the stomach is part of the gastrointestinal tract, and excellent evidence exists that vitamin D reduces the risk of colorectal cancer; the evidence for esophageal cancer is very good. Thus, the evidence that UVB and vitamin D reduce the risk of gastric cancer is strong.

NHL: All the U.S. ecological studies and the study in Spain (females) found inverse correlations between UVB indices and NHL mortality rates. Very good evidence from a pooled analysis of case–control studies indicates that personal UV irradiance is associated with reduced risk of NHL (58). The fact that NHL mortality rates are highest in the Midwest (50) implicates farming as a risk factor (59). A prospective study of those diagnosed with NHL in Iowa and Minnesota found improved survival rates for those with diffuse large B-cell lymphoma and T-cell lymphoma; these types of NHL represented 45% of all patients (60).

Hodgkin's lymphoma: Two U.S. studies and one single-country study (Spain, females) found inverse correlations between a solar UVB index and incidence and/or mortality rates of Hodgkin's lymphoma. Epstein-Barr virus (EBV) is a risk factor for Hodgkin's lymphoma, and vitamin D reduces the risk of EBV infection (61). Hodgkin's lymphoma incidence rates are highest in spring (62). Those diagnosed with Hodgkin's lymphoma in summer in Norway survive longer than those diagnosed in winter (63).

Bladder cancer: All the U.S. studies found an inverse correlation between solar UVB and bladder cancer mortality rate, as did a study in China. A study in New Hampshire found a significant inverse correlation between vitamin D intake and incidence of bladder cancer (64). A NCCS with about a 15-year follow-up period found a significantly reduced risk of bladder cancer for male smokers in Finland with lower serum 25(OH)D at time of enrollment (65).

Endometrial cancer: Two of the U.S. studies and the study from France found inverse correlations between solar UVB indices and endometrial cancer. A NCCS in Sweden found a significant inverse correlation between use of sunbeds and incidence of endometrial cancer (66). That article suggested that raising vitamin D levels in winter explained the association.

Ovarian cancer: Five of the ecological studies reviewed here found an inverse correlation between solar UVB and ovarian mortality rate. A death certificate study in the U.S. found risk of ovarian cancer reduced with respect to solar UVB doses at place of residence and physical activity but not with respect to indoor/outdoor occupation (67). A meta-analysis of 10 observational studies, mostly NCCS, found a summary relative risk of 0.83 (95% confidence interval, 0.63-1.08) for an increase of 25(OH)D by 20 ng/mL (p=0.16) (68). A recent NCCS reported an inverse correlation between serum 25(OH)D level at time of enrollment with up to a 6.4-year mean follow-up to diagnosis of ovarian cancer (69). Thus, the evidence that UVB and vitamin D reduce the risk of ovarian cancer is reasonably strong.

Pancreatic cancer: Pancreatic cancer was found to be inversely correlated with solar UVB in two U.S. studies and in studies in Australia, Japan, and Spain, as well as in the multicountry study for males but not significantly for females. Pesticides are a risk factor for pancreatic cancer (69) and may account for the higher mortality rate for pancreatic cancer in the Midwest. Chemical pollutants emitted by industrial plants may account for the high mortality rate in Louisiana (70). Smoking is an important risk factor for pancreatic cancer, which may mask some of the UVB effect in the United States because of an imperfect index of smoking (lung cancer mortality rates).

Studies have inversely correlated vitamin D with both oral vitamin D intake (24) and serum 25(OH)D (22). Studies that found a direct correlation with serum 25(OH)D level were NCCS with long follow-up times (16.5 years (71) and 6.63 years (25)), which has been identified as a significant problem (28). Thus, reasonable evidence exists that UVB and vitamin D reduce the risk of pancreatic cancer, but further research to confirm this link is necessary.

Esophageal cancer: All the U.S. and single-country studies—except Australia, for whom there are no data—reported inverse correlations with respect to UVB indices for esophageal cancer. Re-examining the regression analysis in (7), it appears that there is no correlation with lung cancer, the index of smoking, in the analysis for males. Without lung cancer in the analysis, only July UVB and alcohol consumption were significant risk-modifying factors with the same impact but different signs, explaining 70% of the variance for males. For females, lung cancer appears to be a risk factor, based on higher mortality rates in the states on the west coast, the Gulf of Mexico, and the Atlantic Ocean. However, some of the lung cancer rates along the coast could be due to ship building activities involving asbestos (72). Omitting lung cancer, alcohol consumption and UVB explained 64% of the variance, with alcohol being much more important than UVB.

Five observational studies found conflicting results between vitamin D indices and risk of esophageal cancer. The first, a NCCS with a 5.25 year follow-up period in China, found a direct correlation between prediagnostic serum 25(OH)D level with incidence of esophageal squamous cell carcinoma (ESCC) for males but not females (73). ESCC is the most common type of esophageal cancer in Asia and southern Europe. The second, a cross-sectional study in Linxian, China, found a direct correlation between serum 25(OH)D and squamous dysplasia, a common precursor for ESCC, for both males and females (74). The third, a pair of case–control studies in Italy, found an inverse correlation between oral vitamin D intake and incidence of esophageal cancer (75). The fourth, a pooled NCCS, found no correlation between serum 25(OH)D level and incidence of esophageal cancer with a mean follow-up time of 6.63 years (25). The fifth, a case–control study in Ireland, found a direct correlation between oral vitamin D intake and esophageal adenocarcinoma (76). Esophageal adenocarcinoma accounts for over half of esophageal cancers in the U.S. Some problems with these studies include that the oral intake studies had low intake levels, less than 400 IU/d, which is generally too low to have an impact on any health outcome other than rickets, and that five and six years of follow-up may be too long to rely on a single serum 25(OH)D level (27, 28). It is thought that the ecological studies provide stronger results regarding the role of vitamin D in the risk of esophageal cancer, but these observational studies provide some doubt.

Lung cancer: Ecological studies of UVB and lung cancer risk are hampered because of the limited information on smoking rates several decades before the periods of the lung cancer rate data. The multicountry study used cigarette sales data for 1980-82 for lung cancer incidence rates in 2002. The UVB indices including clouds and anthropogenic aerosols contributed 10%-15% to the regression-adjusted R2 value. However, serum 25(OH)D levels can predict survival in early-stage non-small cell lung cancer (77). A recent review summarized the evidence that vitamin D reduces the risk of lung cancer (78).

Cervical cancer: Two studies (7, 33) found inverse correlation between solar UVB indices and cervical cancer mortality (7, 34), and two studies in China and France found inverse correlation with cervical cancer incidence rate (30, 34). Smoking is an important risk factor for cervical cancer (79), complicating the ecological studies. Because the other U.S. study compared only northern with southern states (8), and lung cancer rates are much higher in the south than in the north (50), this may have limited that study's ability to find an inverse correlation with respect to solar UVB. A case–control study in Japan found a significantly reduced risk of cervical neoplasia with increasing oral vitamin D intake (80).

Renal cancer: All the U.S. studies and the multicountry study, but none of the other single-country studies, found inverse correlations with the UVB index. In the U.S., the highest rates of renal cancer mortality rate are met in the Midwest. Pesticides used in agriculture might account for the high rates in the Midwest. However, a study to address this question found no correlation with pesticide use in four wheat-growing Midwest states (81). Evidently, other factors such as diet are more important in affecting the risk for renal cancer than is vitamin D.

Vulvar cancer: One U.S. study inversely correlated a vitamin D index with vulvar cancer incidence and mortality rates (8). Because the geographical variation of vulvar cancer mortality rates in the U.S has the typical vitamin D–sensitive cancer pattern (high in the Northeast, low in the Southwest), it seems likely that vitamin D reduces the risk for vulvar cancer.

Those with Limited Evidence

Gallbladder cancer: Two U.S. studies (7, 8), one in Japan (36), and one in Spain (38) found inverse correlations between UVB indices and gallbladder cancer incidence and/or mortality rate. Because this is a rare type of cancer, little additional evidence exist regarding vitamin D's role in risk.

Brain cancer: Two of the U.S. studies (7, 8), the study in Spain (38), and a multicountry study (48) found inverse correlations with UVB indices. However, inspection of the geographical variation of brain cancer mortality rate in the U.S. (50) indicates that rates are low in the Northeast and Southwest but high in the Southeast, Midwest, and Northwest. The high rates in the Southeast could be related to diet or smoking, whereas the high rates in the Midwest could be related to farming (82).

Multiple myeloma: Two of the U.S. studies and the study in Spain found inverse correlations between the solar UVB indices and multiple myeloma mortality rates. However, the Midwest seems to be the U.S. region with the highest mortality rates, rather than the Northeast, suggesting that agricultural pesticides may be responsible. A review of studies in the U.S. found farmers at increased risk of multiple myeloma, with microorganisms, solvents, and pesticides possible contributing factors (83). A study in Minnesota found that at time of diagnosis, the fraction with deficient serum 25(OH)D levels increased progressively as the stage at diagnosis increased (84).

Leukemia: Only two studies, one in the U.S. (8) and a study in China (34), found inverse correlations between solar UVB and leukemia mortality rate. An ecological study in China found an inverse correlation between annual solar UVB doses and leukemia incidence and mortality rates in rural regions but found an increased risk in urban regions (34). Those living in rural regions are much more likely to spend significant time outdoors, possibly by working in agriculture. Thus, this study offers evidence of a beneficial effect of UVB irradiance in reducing the risk of leukemia.

As with several other types of cancer, the highest rates are in the Midwest U.S. Farming is an important risk factor for leukemia (85). The NCCS with respect to a serum 25(OH)D level index found a statistically significant inverse correlation for male health professionals (22). The failure of other studies to confirm these two findings indicates that the beneficial effect of vitamin D on all leukemia types is weak. However, some types of leukemia may exist for which the effect is strong.

Prostate cancer: Two U.S. studies as well as studies in Australia and France found inverse correlations with the solar UVB indices. However, the geographical variation of prostate cancer mortality rate in the U.S. is much different from that of the vitamin D-sensitive types of cancer such as breast, colon, and rectal; for one thing, there is a more pronounced latitudinal increase, and for another, the highest mortality rates are in the Northwest and lowest in the Southeast, whereas for the other cancers, the highest rates are in the Northeast and lowest in the Southwest (50). The latitudinal finding led to a study suggesting that viral infections were involved (86). However, there is little support for this hypothesis. The observation that prostate cancer has a different geographical variation than commonly accepted vitamin D-sensitive types of cancer such as breast, colon, ovarian, and rectal cancer led to the discovery that prostate cancer mortality rates in the U.S. were highly correlated with ethnic background (87). In addition, African-Americans have about twice the prostate cancer mortality rate as white-Americans (50). Latitude is also an index of prevalence of apolipoprotein E-4 (APOE4) for those living in their ancestral homelands. In the U.S., those with Northern European ancestry are more likely to live at higher latitudes, while those with Southern European or Hispanic ancestry are more likely to live at lower latitudes. In a multicountry ecological study for 102 non-African countries in which APOE4 allele prevalence, diet (cereals/grains), and per capita gross domestic product were included, the model explained 67% and 56% of the variance for prostate cancer incidence and mortality rates, respectively, with APOE4 prevalence accounting for about one-third (88). This study does not prove that APOE4 is a risk factor for prostate cancer, but does show that there are other possible explanations for the geographical variation of prostate cancer rates. Note that nearly all studies of prostate cancer incidence with respect to prediagnostic serum 25(OH)D level have reported no correlation (21, 28). One study reporting a U-shaped relationship was an NCCS with a follow-up period of 15-17 years (89). However, some evidence indicates that higher serum 25(OH)D levels are associated with increased cancer-specific and all-cause survival after diagnosis of prostate cancer (90).

Laryngeal cancer: The two U.S. studies found different results for laryngeal cancer with respect to solar UVB indices (7, 8). When the Midwest states are omitted, UVB is associated with reduced risk for females but not for males. Smoking is an important risk factor for laryngeal cancer. Whether vitamin D reduces risk is not clear.

Thyroid cancer: One U.S. study and the study in Spain found inverse correlations between the UVB indices and thyroid cancer incidence or mortality rates. However, in the U.S., this was only the case for females. Vitamin D receptor alleles affect thyroid cancer prognosis (91, 92).

Melanoma: Only one study found an inverse correlation between a UVB index and melanoma mortality rates, that for females in Spain. Other evidence indicate that vitamin D (93) and sun exposure (94) reduce the risk of melanoma. Another mechanism of UV irradiance in reducing risk of melanoma is the generation of elastosis (95).

Oral/pharyngeal cancer: Two of the U.S. studies found inverse correlations between solar UVB indices and oral/pharyngeal cancer, but none of the single-country studies did. An NCCS from Harvard found a statistically significant relative risk of about 0.3 for male health professionals with respect to a vitamin D index (22).

General comments: The strength of the association of a solar UVB index with cancer outcome is affected to some extent by the relative roles of vitamin D from the UVB doses and the values of the other risk-modifying factors. Sometimes, the indices used for the effect of smoking might mask the effect of solar UVB, such as for cervical and pancreatic cancer.

The advantages of the ecological approach include the many cases available, the many datasets available for ecological studies, that publicly available information is generally available for confounding factors, that designing ‘experiments’ is easy, and that data from many periods are available. In contrast to other epidemiological study types such as case–control studies and NCCS, the UVB–vitamin D index generally covers many years of life, with an emphasis on the later years of the case patients unless they moved shortly before dying. Moreover, ecological studies entail minimal time and cost.

Ecological studies use indices of solar UVB doses, which can be considered an indirect measure of vitamin D. Vitamin D production is the only factor proposed to explain the findings. UV irradiance is an important risk factor for development of basal cell carcinoma and squamous cell carcinoma (13-15). A registry study found significant inverse correlations between those diagnosed with NMSC in sunnier countries and three types of internal cancer in a statistically significant manner (liver and gallbladder, pancreatic, and prostate) and six types of cancer in a nonsignificant manner (bladder, colon, gastric, ovarian, rectal, and renal), but not in less sunny countries (13). It was suggested that in sunnier countries, people were able to expose more body surface area (15). A recent study found that those diagnosed with NMSC in Detroit, Michigan, had higher prediagnostic serum 25(OH)D levels (18).

Dental caries are inversely correlated with solar UVB doses and vitamin D. Several studies starting in 1865 found tooth loss and dental caries inversely correlated with summertime solar UVB doses (96). Vitamin D induces production of cathelicidin, which reduces the burden of oral bacteria that cause dental caries (96). Thus, this disease provides an analogous result to the findings for the cancer in (7).

Two ecological studies reported results for both cancer incidence and mortality rates with respect to solar UVB indices (8, 34). One reason for the finding that inverse correlations between solar UVB doses and cancer mortality rate than incidence rate, is that more risk-modifying factors might affect cancer incidence than affect cancer survival. Mechanisms of vitamin D that affect survival include reduced risk of angiogenesis and metastasis (97).

Other Risk-modifying Factors

Three additional ecological studies of cancer in the United States were also carried out, examining the possible role of other risk-modifying factors on cancer mortality rates. One tested the hypothesis that wintertime vitamin D levels were important in the risk of some types of cancer, owing to higher rates of viral infections in winter that might be related to cancer risk, such as demonstrated for Hodgkin's lymphoma and multiple sclerosis (86). Cancer types with a higher risk associated with latitude or temperature in January included bladder, gastric, prostate, testicular, and thyroid cancer; Hodgkin's lymphoma; and NHL. There is limited evidence that viral infections play a role regarding risk for prostate cancer (98). It also appears that prostate cancer may be related to ethnic background in general and APOE alleles in particular, with APOE4 associated with higher risk (88). Working as a farmer seems to be a risk factor for Hodgkin's lymphoma (99) and NHL (59, 100), which could explain some of the elevated levels at higher latitudes. H. pylori, rather than viruses, is an important risk factor for gastric cancer. Recent evidence exists that maternal EBV infections are associated with increased risk of testicular cancer in offspring (101). Limited evidence also exists for a role of EBV infection in the risk of thyroid cancer (102). However, for these and the other cancer types, the viral infection hypothesis as proposed is probably not valid.

A second study examined the possible role of dietary iron and zinc in affecting the risk of cancer mortality rates in the United States (103). Data on iron and zinc were available only for four large regions. Iron was associated with increased risk for 10 types of cancer, whereas zinc inversely correlated with 12 types of cancer. Because the iron and zinc values were obtained from dietary factors, the findings could be related to other components of such dietary factors. Later work found an increased risk of endometrial cancer from dietary iron intake (104) and colorectal cancer from heme iron from meat (105), as well as evidence that zinc protects against cancer (106). No effect of dietary iron was reported for bladder cancer (107), in agreement with the ecological study.

A third ecological study investigated the possible role of air pollution in cancer risk (108). The index used was an acid deposition map for the United States for 1985. The acidity level was highest in the Northeast and lowest in the West. Coal-fired power plants are an important source of acid rain in the Northeast. Cancer types having elevated risk with respect to acid deposition instead of summertime solar UVB doses included cervical, laryngeal, lung, nasopharyngeal, and oral cancer. Smoking is an important risk factor for all types of cancer. Black carbon and aromatic hydrocarbons are an important component of both cigarette smoke and combustion products of coal, diesel fuel, and wood, but not gasoline or oil. Aromatic hydrocarbons adsorb to black carbon and are associated with increased risk of cancer (109). It was assumed that the acid deposition index was a measure of black carbon and aromatic hydrocarbons in the air breathed in the various states. Acid deposition was also associated with seven other types of cancer along with solar UVB. The cross-correlation coefficient between acid deposition and solar UVB dose was 0.37 (p=0.01), so some of the correlations found, could be due to overlap between the two indices. Nonetheless, this study offers hypothesis-generating evidence that air pollution plays a role in cancer in general. Air pollution is an important risk factor for lung cancer and cardiovascular disease (110).

Hill's Criteria for Causality

As discussed in 2009 (111), Hill's criteria were generally satisfied for breast and colorectal cancer, with good evidence for 10 other types of cancer: bladder, esophageal, gallbladder, gastric, ovarian, rectal, renal, and uterine corpus cancer, as well as Hodgkin's and NHL. The findings discussed here support these findings and add cervical and vulvar cancers to the list.

Vitamin D Pooling Project

The Vitamin D Pooling Project study found no correlation between prediagnostic serum 25(OH)D and incidence of six rare cancer sites: endometrial, esophageal, gastric, kidney, NHL, and ovarian cancers (25). However, a direct correlation was found with pancreatic cancer (25). The evidence from ecological studies supports a beneficial role of UVB irradiance and vitamin D for all of these types of cancer. As noted earlier, the long follow-up time, 6.63 years, probably explains why inverse correlations were not found.

U-Shaped Relationship with 25(OH)D

Several NCCS found direct or U-shaped relations between cancer incidence rates and the prediagnostic serum 25(OH)D level (71, 89, 112). Ecological studies can be used to look for similar findings. In the U.S., as summertime UVB dose increases, cancer mortality rates and dental caries rates decrease rapidly at first and then meet a plateau at higher doses (6, 91). The flattening at higher doses could be due either to a saturation of the beneficial effect of vitamin D (54), or to people spending less time in the sun because of the heat.

Summary and Conclusion

Ecological studies of cancer incidence and mortality rates give some of the strongest evidence that solar UVB is associated with reduced risk of many types of cancer. The results are reasonably consistent between different cancer types and countries. No mechanism other than vitamin D production has been proposed to explain the effect of UVB irradiance on reducing cancer risk. One barrier to adopting the UVB–vitamin D–cancer hypothesis is that observational studies, generally NCCS, have reported inconsistent results with respect to serum 25(OH)D levels. As discussed here and elsewhere, an important problem in using NCCS is that because of the long follow-up periods after enrollment and serum collection, the 25(OH)D level determined from serum draw at time of enrollment loses predictive value beyond 3-7 years of follow-up. Policy-makers also seem to be waiting for a definitive randomized controlled trial (RCT) of vitamin D to provide convincing evidence that vitamin D reduces cancer risk (113). The only RCT investigating cancer incidence with respect to vitamin D that used sufficient vitamin D (1100 IU/d) to produce an effect, found a 77% reduction in all-cancer incidence rates between the ends of the first and fourth years (114). Many problems are associated with RCTs, including cost and time involved; the availability of few cases for rarer types of cancer; poor compliance; other sources of vitamin D, both oral and from UVB irradiance; that the beneficial effect of vitamin D depends on serum 25(OH)D level in the absence of oral intake (54); and that no uniform relationship exists between oral vitamin D intake and serum 25(OH)D level (115). Waiting for a definitive RCT may subject countless people to needless cancer and other chronic and infectious diseases. Based on observational studies, it was calculated that if serum 25(OH)D levels were raised globally from a mean value of about 54 nmol/l to 110 nmol/l, life expectancies could be increased by two years (116).

Footnotes

  • Disclosure

    Funding was received from the UV Foundation (McLean, VA), Bio-Tech-Pharmacal (Fayetteville, AR), the Vitamin D Council (San Luis Obispo, CA), and the Vitamin D Society (Canada).

  • Received September 5, 2011.
  • Revision received November 3, 2011.
  • Accepted November 4, 2011.
  • Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Garland CF,
    2. Garland FC
    : Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-223, 1980.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Garland FC,
    2. Garland CF,
    3. Gorham ED,
    4. Young JF
    : Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622, 1990.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lefkowitz ES,
    2. Garland CF
    : Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23: 1133-136, 1994.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Schwartz GG,
    2. Hulka BS
    : Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10: 1307-1311, 1990.
    OpenUrlPubMed
  5. ↵
    1. Hartge P,
    2. Devesa SS,
    3. Grauman D,
    4. Fears TR,
    5. Fraumeni JF Jr..
    : Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88: 298-300, 1996.
    OpenUrlFREE Full Text
  6. ↵
    1. Grant WB
    : An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875, 2002.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Grant WB,
    2. Garland CF
    : The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26: 2687-2699, 2006.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Boscoe FP,
    2. Schymura MJ
    : Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2000. BMC Cancer 6: 264, 2006.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Mohr SB
    : A brief history of vitamin D and cancer prevention. Ann Epidemiol 19: 79-83, 2009.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Grant WB,
    2. Mohr SB
    : Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 19: 446-454, 2009.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Rhee HV,
    2. Coebergh JW,
    3. Vries ED
    : Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev 18: 458-475, 2009.
    OpenUrlCrossRef
  12. ↵
    1. Peller S,
    2. Stephenson CS
    : Skin irritation and cancer in the United States Navy. Am J Med Sci 194: 326-333, 1937.
    OpenUrlCrossRef
  13. ↵
    1. Tuohimaa P,
    2. Pukkala E,
    3. Scelo G,
    4. Olsen JH,
    5. Brewster DH,
    6. Hemminki K,
    7. Tracey E,
    8. Weiderpass E,
    9. Kliewer EV,
    10. Pompe-Kirn V,
    11. McBride ML,
    12. Martos C,
    13. Chia KS,
    14. Tonita JM,
    15. Jonasson JG,
    16. Boffetta P,
    17. Brennan P
    : Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation. Eur J Cancer 43: 1701-1712, 2007.
    OpenUrlCrossRefPubMed
    1. Grant WB
    : A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol 103: 668-674, 2007.
    OpenUrlCrossRef
  14. ↵
    1. Grant WB
    : The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours. Eur J Cancer 44: 12-15, 2008.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Soerjomataram I,
    2. Louwman WJ,
    3. Lemmens VE,
    4. Coebergh JW,
    5. de Vries E
    : Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol 167: 1421-1429, 2008.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. de Vries E,
    2. Soerjomataram I,
    3. Houterman S,
    4. Louwman MW,
    5. Coebergh JW
    : Decreased risk of prostate cancer after skin cancer diagnosis: A protective role of ultraviolet radiation? Am J Epidemiol 165: 966-972, 2007.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Eide MJ,
    2. Johnson DA,
    3. Jacobsen GR,
    4. Krajenta RJ,
    5. Rao DS,
    6. Lim HW,
    7. Johnson CC
    : Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort. Arch Dermatol 2011 Aug 15. [Epub ahead of print]
  18. ↵
    1. Yin L,
    2. Grandi N,
    3. Raum E,
    4. Haug U,
    5. Arndt V,
    6. Brenner H
    : Meta-analysis: Serum vitamin D and breast cancer risk. Eur J Cancer 46: 2196-2205, 2010.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Yin L,
    2. Grandi N,
    3. Raum E,
    4. Haug U,
    5. Arndt V,
    6. Brenner H
    : Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30: 113-125, 2009.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Gandini S,
    2. Boniol M,
    3. Haukka J,
    4. Byrnes G,
    5. Cox B,
    6. Sneyd MJ,
    7. Mullie P,
    8. Autier P
    : Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128: 1414-424, 2011.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Giovannucci E,
    2. Liu Y,
    3. Rimm EB,
    4. Hollis BW,
    5. Fuchs CS,
    6. Stampfer MJ,
    7. Willett WH
    : Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. JNCI 98: 451-459, 2006.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Toriola AT,
    2. Surcel HM,
    3. Calypse A,
    4. Grankvist K,
    5. Luostarinen T,
    6. Lukanova A,
    7. Pukkala E,
    8. Lehtinen M
    : Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case–control study. Eur J Cancer 46: 2799-2805, 2010.
    OpenUrlPubMed
  23. ↵
    1. Skinner HG,
    2. Michaud DS,
    3. Giovannucci E,
    4. Willett WC,
    5. Colditz GA,
    6. Fuchs CS
    : Vitamin D intake and the risk of pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prevention 15: 1688-1695, 2006.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Helzlsouer KJ,
    2. For the VDPP Steering Committee
    : Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epi 172: 4-9, 2010.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Robien K,
    2. Cutler GJ,
    3. Lazovich D
    : Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control 18: 775-782, 2007.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Lim U,
    2. Freedman DM,
    3. Hollis BW,
    4. Horst RL,
    5. Purdue MP,
    6. Chatterjee N,
    7. Weinstein SJ,
    8. Morton LM,
    9. Schatzkin A,
    10. Virtamo J,
    11. Linet MS,
    12. Hartge P,
    13. Albanes D
    : A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124: 979-986, 2009.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Grant WB
    : Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines, Dermato-Endocrinology 3: 199-204, 2011.
    OpenUrl
  28. ↵
    1. Fédération Nationale des Observatoires Régionaux de la Santé (FNORS)
    : Le cancer dans les régions de France 2005; http://www.fnors.org/fnors/ors/travaux/synthesekcer.pdf (accessed June 13, 2010).
  29. ↵
    1. Grant WB
    : An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production. Deramato-Endocrinology 2: 62-67, 2010.
    OpenUrl
  30. ↵
    1. Astbury A
    : Non uniformity in cancer mortality in the USA and Australia appears to share a common pathway. Triumf report, TRI-PP-05-01, 2005. http://www.triumf.ca/publications/pub/arch05/pp-05-01.pdf (accessed Nov. 1, 2011).
    1. Neale RE,
    2. Youlden DR,
    3. Krnjacki L,
    4. Kimlin MG,
    5. van der Pols JC
    : Latitude variation in pancreatic cancer mortality in Australia. Pancreas 38: 387-390, 2009.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Grant WB
    : Does solar ultraviolet irradiation affect cancer mortality rates in China? Asian Pac J Cancer Prev 8: 236-242, 2007.
    OpenUrlPubMed
  32. ↵
    1. Chen W,
    2. Clements M,
    3. Rahman B,
    4. Zhang S,
    5. Qiao Y,
    6. Armstrong BK
    : Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 21: 1701-1709, 2010.
    OpenUrlCrossRefPubMed
    1. Kato I,
    2. Tajima K,
    3. Kuroishi T,
    4. Tominaga S
    : Latitude and pancreatic cancer. Jpn J Clin Oncol 15: 403-413, 1985.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Mizoue T
    : Ecological study of solar radiation and cancer mortality in Japan. Health Phys 87: 532-538, 2004.
    OpenUrlCrossRefPubMed
    1. Kinoshita S,
    2. Wagatsuma Y,
    3. Okada M
    : Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. Int J Health Geogr 6: 34, 2007.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Grant WB
    : An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int J Cancer 120: 1123-1127, 2007.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Grant WB
    : An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption, and urban/rural residence. Deramato-Endocrinology 2: 68-76, 2010.
    OpenUrl
  36. ↵
    1. Astbury A
    : Cancer mortality, cosmic ray neutron dose, and summer solar UV-B flux share similar geographical distributions in the USA. Triumf report TRI-PP-05-24. June 2005. http://legacyweb.triumf.ca/publications/pub/arch05/pp-05-24.pdf (accessed Nov. 1, 2011).
  37. ↵
    1. Garland CF,
    2. Mohr SB,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Role of ultraviolet-B irradiance and vitamin D in the prevention of ovarian cancer. Am J Prev Med 31: 512-514, 2006.
    OpenUrlCrossRefPubMed
    1. Mohr SB,
    2. Gorham ED,
    3. Garland CF,
    4. Grant WB,
    5. Garland FC
    : Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer 119: 2705-2709, 2006.
    OpenUrlCrossRefPubMed
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer: an ecological study of 107 countries. Prev Med 45: 327-331, 2007.
    OpenUrlCrossRefPubMed
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer? J Epidemiol Community Health 62: 69-74, 2008.
    OpenUrlAbstract/FREE Full Text
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J 141: 255-260, 2008.
    OpenUrl
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Are ultraviolet B irradiance and serum 25-hydroxyvitamin D inversely associated with incidence rates of bladder cancer in 174 countries, Am J Prev Med 38: 296-302, 2010.
    OpenUrlPubMed
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Ultraviolet B irradiance and vitamin D status are inversely associated with incidence rates of pancreatic cancer worldwide. Pancreas 39: 669-674, 2010.
    OpenUrlPubMed
  38. ↵
    1. Mohr SB,
    2. Gorham ED,
    3. Garland CF,
    4. Grant WB,
    5. Garland FC
    : Low ultraviolet B and increased risk of brain cancer: An ecological study of 175 countries. Neuroepidemiology 35: 281-290, 2010.
    OpenUrlPubMed
  39. ↵
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Grant WB,
    5. Garland FC
    : Ultraviolet B and incidence rates of leukemia worldwide. Am J Prev Med 41: 68-74, 2011.
    OpenUrlPubMed
  40. ↵
    1. Devesa SS,
    2. Grauman DJ,
    3. Blot WJ,
    4. Pennello GA,
    5. Hoover RN,
    6. Fraumeni JF Jr.
    : Atlas of Cancer Mortality in the United States, 1950-1994. NIH Publication No. 99-4564, 1999. http://ratecalc.cancer.gov/ratecalc//(accessed Nov. 1, 2011)
    1. Uehara M,
    2. Takahashi K,
    3. Hoshuyama T,
    4. Pan G,
    5. Feng Y
    : Geographical correlation between ambient UVB level and mortality risk of leukemia in Japan. Environ Res 92: 78-84, 2003.
    OpenUrlPubMed
    1. Takahashi K,
    2. Pan G,
    3. Feng Y,
    4. Ohtaki M,
    5. Watanabe S,
    6. Yamaguchi N
    : Regional correlation between estimated UVB levels and skin cancer mortality in Japan. J Epidemiol 9(6 Suppl): S123-S128, 1999.
    OpenUrlPubMed
  41. ↵
    1. Hill AB
    : The environment and disease: Association or causation? Proc R Soc Med 58: 295-300, 1965.
    OpenUrlPubMed
  42. ↵
    1. Grant WB
    : Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 101: 130-136, 2010.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Oh EY,
    2. Ansell C,
    3. Nawaz H,
    4. Yang CH,
    5. Wood PA,
    6. Hrushesky WJ
    : Global breast cancer seasonality. Breast Cancer Res Treat 123: 233-243, 2010.
    OpenUrlPubMed
  44. ↵
    1. Bouvier AM,
    2. Remontet L,
    3. Jougla E,
    4. Launoy G,
    5. Grosclaude P,
    6. Buémi A,
    7. Tretarre B,
    8. Velten M,
    9. Dancourt V,
    10. Menegoz F,
    11. Guizard AV,
    12. Macé Lesec'h J,
    13. Peng J,
    14. Bercelli P,
    15. Arveux P,
    16. Estève J,
    17. Faivre J
    : Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol 28: 877-881, 2004.
    OpenUrlPubMed
  45. ↵
    1. Nasri H,
    2. Baradaran A
    : The influence of serum 25-hydroxy vitamin D levels on Helicobacter pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi J Kidney Dis Transpl 18: 215-219, 2007.
    OpenUrlPubMed
  46. ↵
    1. Kricker A,
    2. Armstrong BK,
    3. Hughes AM,
    4. Goumas C,
    5. Smedby KE,
    6. Zheng T,
    7. Spinelli JJ,
    8. De Sanjose S,
    9. Hartge P,
    10. Melbye M,
    11. Willett EV,
    12. Becker N,
    13. Chiu BC,
    14. Cerhan JR,
    15. Maynadie M,
    16. Staines A,
    17. Cocco P,
    18. Boffeta P,
    19. for the Interlymph Consortium
    : Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium. Int J Cancer 122: 144-154, 2008.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Khuder SA,
    2. Schaub EA,
    3. Keller-Byrne JE
    : Meta-analyses of non-Hodgkin's lymphoma and farming. Scand J Work Environ Health 24: 255-261, 1998.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Drake MT,
    2. Maurer MJ,
    3. Link BK,
    4. Habermann TM,
    5. Ansell SM,
    6. Micallef IN,
    7. Kelly JL,
    8. Macon WR,
    9. Nowakowski GS,
    10. Inwards DJ,
    11. Johnston PB,
    12. Singh RJ,
    13. Allmer C,
    14. Slager SL,
    15. Weiner GJ,
    16. Witzig TE,
    17. Cerhan JR
    : Vitamin D isufficiency and pognosis in non-Hodgkin's lmphoma. J Clin Oncol 28: 4191-4198, 2010.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Zwart SR,
    2. Mehta SK,
    3. Ploutz-Snyder R,
    4. Bourbeau Y,
    5. Locke JP,
    6. Pierson D,
    7. Smith SM
    : Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr virus reactivation. J Nutr 141: 692-697, 2011.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Douglas AS,
    2. Brown T,
    3. Reid D
    : Infectious mononucleosis and Hodgkin's disease–a similar seasonality. Leuk Lymphoma 23: 323-331, 1996.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Porojnicu AC,
    2. Dahlback A,
    3. Moan J
    : Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol 624: 43-54, 2008.
    OpenUrlPubMed
  52. ↵
    1. Brinkman MT,
    2. Karagas MR,
    3. Zens MS,
    4. Schned A,
    5. Reulen RC,
    6. Zeegers MP
    : Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control 21: 609-619, 2010.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Mondul AM,
    2. Weinstein SJ,
    3. Männistö S,
    4. Snyder K,
    5. Horst RL,
    6. Virtamo J,
    7. Albanes D
    : Serum vitamin D and risk of bladder cancer. Cancer Res 70: 9218-9223, 2010.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    1. Epstein E,
    2. Lindqvist PG,
    3. Geppert B,
    4. Olsson H
    : A population-based cohort study on sun habits and endometrial cancer. Br J Cancer 101: 537-540, 2009.
    OpenUrlPubMed
  55. ↵
    1. Freedman DM,
    2. Dosemeci M,
    3. McGlynn K
    : Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case–control study. Occup Environ Med 59: 257-262, 2002.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Yin L,
    2. Grandi N,
    3. Raum E,
    4. Haug U,
    5. Arndt V,
    6. Brenner H
    : Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121: 369-375, 2011.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Clary T,
    2. Ritz B
    : Pancreatic cancer mortality and organochlorine pesticide exposure in California, 1989-1996. Am J Ind Med 43: 306-313, 2003.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Pickle LW,
    2. Gottlieb MS
    : Pancreatic cancer mortality in Louisiana. Am J Public Health 70: 256-259, 1980.
    OpenUrlPubMed
  59. ↵
    1. Stolzenberg-Solomon RZ,
    2. Vieth R,
    3. Azad A,
    4. Pietinen P,
    5. Taylor PR,
    6. Virtamo J,
    7. Albanes D
    : A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66: 10213-10219, 2006.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Jemal A,
    2. Grauman D,
    3. Devesa S
    : Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970-94. Am J Ind Med 37: 512-521, 2000.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Chen W,
    2. Dawsey SM,
    3. Qiao YL,
    4. Mark SD,
    5. Dong ZW,
    6. Taylor PR,
    7. Zhao P,
    8. Abnet CC
    : Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97: 123-128, 2007.
    OpenUrlCrossRefPubMed
  62. ↵
    1. Abnet CC,
    2. Chen W,
    3. Dawsey SM,
    4. Wei WQ,
    5. Roth MJ,
    6. Lie B,
    7. Lu N,
    8. Taylor PR,
    9. Qiao YL
    . Serum: 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16: 1889-1893, 2007.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Lipworth L,
    2. Bender TJ,
    3. Rossi M,
    4. Bosetti C,
    5. Negri E,
    6. Talamini R,
    7. Giacosa A,
    8. Franceschi S,
    9. McLaughlin JK,
    10. La Vecchia C
    : Dietary vitamin D intake and cancers of the colon and rectum: a case-control study in Italy. Nutr Cancer 61: 70-75, 2009.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Mulholland HG,
    2. Murray LJ,
    3. Anderson LA,
    4. Cantwell MM
    : Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br J Nutr 106: 732-741, 2011.
    OpenUrlCrossRefPubMed
  65. ↵
    1. Zhou W,
    2. Heist RS,
    3. Liu G,
    4. Asomaning K,
    5. Neuberg DS,
    6. Hollis BW,
    7. Wain JC,
    8. Lynch TJ,
    9. Giovannucci E,
    10. Su L,
    11. Christiani DC
    : Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25: 479-485, 2007.
    OpenUrlAbstract/FREE Full Text
  66. ↵
    1. Ramnath N,
    2. Kim S,
    3. Christensen PJ
    : Vitamin D and lung cancer. Expert Rev Respir Med 5: 305-309, 2011.
    OpenUrlPubMed
  67. ↵
    1. Fonseca-Moutinho JA
    : Smoking and cervical cancer. ISRN Obstet Gynecol 2011: 847684, 2011.
    OpenUrlPubMed
  68. ↵
    1. Hosono S,
    2. Matsuo K,
    3. Kajiyama H,
    4. Hirose K,
    5. Suzuki T,
    6. Kawase T,
    7. Kidokoro K,
    8. Nakanishi T,
    9. Hamajima N,
    10. Kikkawa F,
    11. Tajima K,
    12. Tanaka H
    : Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. Eur J Clin Nutr 64: 400-409, 2010.
    OpenUrlPubMed
  69. ↵
    1. Schreinemachers DM
    : Cancer mortality in four northern wheat-producing states. Environ Health Perspect 108: 873-881, 2000.
    OpenUrlPubMed
  70. ↵
    1. Khuder SA,
    2. Mutgi AB,
    3. Schaub EA
    : Meta-analyses of brain cancer and farming. Am J Ind Med 34: 252-260, 1998.
    OpenUrlCrossRefPubMed
  71. ↵
    1. Khuder SA,
    2. Mutgi AB
    : Meta-analyses of multiple myeloma and farming. Am J Ind Med 32: 510-516, 1997.
    OpenUrlCrossRefPubMed
  72. ↵
    1. Ng AC,
    2. Kumar SK,
    3. Rajkumar SV,
    4. Drake MT
    : Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 84: 397-400, 2009.
    OpenUrlCrossRefPubMed
  73. ↵
    1. Blair A,
    2. White DW
    : Leukemia cell types and agricultural practices in Nebraska. Arch Environ Health 40: 211-214, 1985.
    OpenUrlPubMed
  74. ↵
    1. Grant WB
    : Hypothesis-Ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol 84: 356-365, 2008.
    OpenUrlCrossRefPubMed
  75. ↵
    1. Brittingham A,
    2. de la Cruz GP
    : Ancestry 2000. Census 2000 Brief C2KBR-35. U.S. Dept. of Commerce Census Bureau. Washington, DC, 2004, p. 9.
  76. ↵
    1. Grant WB
    : A multicountry ecological study of risk-modifying factors for prostate cancer: Apolipoprotein E ε4 as a risk factor and cereals as a risk reduction factor. Anticancer Res 30: 189-199, 2010.
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. Tuohimaa P,
    2. Tenkanen L,
    3. Ahonen M,
    4. Lumme S,
    5. Jellum E,
    6. Hallmans G,
    7. Stattin P,
    8. Harvei S,
    9. Hakulinen T,
    10. Luostarinen T,
    11. Dillner J,
    12. Lehtinen M,
    13. Hakama M
    : Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108: 104-108, 2004.
    OpenUrlCrossRefPubMed
  78. ↵
    1. Fang F,
    2. Kasperzyk JL,
    3. Shui I,
    4. Hendrickson W,
    5. Hollis BW,
    6. Fall K,
    7. Ma J,
    8. Gaziano JM,
    9. Stampfer MJ,
    10. Mucci LA,
    11. Giovannucci E
    : Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 6: e18625, 2011.
    OpenUrlCrossRefPubMed
  79. ↵
    1. Penna -Martinez M,
    2. Ramos-Lopez E,
    3. Stern J,
    4. Hinsch N,
    5. Hansmann ML,
    6. Selkinski I,
    7. Grünwald F,
    8. Vorländer C,
    9. Wahl RA,
    10. Bechstein WO,
    11. Zeuzem S,
    12. Holzer K,
    13. Badenhoop K
    : Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid 19: 623-628, 2009.
    OpenUrlCrossRefPubMed
  80. ↵
    1. Sharma V,
    2. Fretwell D,
    3. Crees Z,
    4. Kerege A,
    5. Klopper JP
    : Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid 20: 1103-1111, 2010.
    OpenUrlCrossRefPubMed
  81. ↵
    1. Millen AE,
    2. Tucker MA,
    3. Hartge P,
    4. Halpern A,
    5. Elder DE,
    6. Guerry D 4th.,
    7. Holly EA,
    8. Sagebiel RW,
    9. Potischman N
    : Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13: 1042-1051, 2004.
    OpenUrlAbstract/FREE Full Text
  82. ↵
    1. Newton-Bishop JA,
    2. Chang YM,
    3. Elliott F,
    4. Chan M,
    5. Leake S,
    6. Karpavicius B,
    7. Haynes S,
    8. Fitzgibbon E,
    9. Kukalizch K,
    10. Randerson-Moor J,
    11. Elder DE,
    12. Bishop DT,
    13. Barrett JH
    : Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 47: 732-741, 2011.
    OpenUrlCrossRefPubMed
  83. ↵
    1. Grant WB
    : Skin aging from ultraviolet irradiance and smoking reduces risk of melanoma: Epidemiological evidence. Anticancer Res 28: 4003-4008, 2008.
    OpenUrlAbstract/FREE Full Text
  84. ↵
    1. Grant WB
    : A review of the role of solar ultraviolet-B irradiance and vitamin D in reducing risk of dental caries. Dermato-Endocrinology 3: 193-198, 2011.
    OpenUrl
  85. ↵
    1. Krishnan AV,
    2. Feldman D
    : Mechanisms of the anticancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51: 311-336, 2011.
    OpenUrlCrossRefPubMed
  86. ↵
    1. Sutcliffe S
    : Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol 6: 1289-1311, 2010.
    OpenUrlPubMed
  87. ↵
    1. Khuder SA,
    2. Mutgi AB,
    3. Schaub EA,
    4. Tano BD
    : Meta-analysis of Hodgkin's disease among farmers. Scand J Work Environ Health 25: 436-441, 1999.
    OpenUrlPubMed
  88. ↵
    1. Keller-Byrne JE,
    2. Khuder SA,
    3. Schaub EA,
    4. McAfee O
    : A meta-analysis of non-Hodgkin's lymphoma among farmers in the central United States. Am J Ind Med 31: 442-444, 1997.
    OpenUrlCrossRefPubMed
  89. ↵
    1. Holl K,
    2. Surcel HM,
    3. Koskela P,
    4. Dillner J,
    5. Hallmans G,
    6. Wadell G,
    7. Kaasila M,
    8. Olafsdottir GH,
    9. Ogmundsdottir HM,
    10. Pukkala E,
    11. Stattino P,
    12. Lehtinen M
    : Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case–control study. APMIS 116: 816-822, 2008.
    OpenUrlCrossRefPubMed
  90. ↵
    1. Dong C,
    2. Hemminki K
    : Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 85: 997-1005, 2001.
    OpenUrlCrossRefPubMed
  91. ↵
    1. Grant WB
    : An ecological study of cancer mortality rates including indices for dietary iron and zinc. Anticancer Res 28: 1955-1963, 2008.
    OpenUrlAbstract/FREE Full Text
  92. ↵
    1. Kallianpur AR,
    2. Lee SA,
    3. Xu WH,
    4. Zheng W,
    5. Gao YT,
    6. Cai H,
    7. Ruan ZX,
    8. Xiang YB,
    9. Shu XO
    : Dietary iron intake and risk of endometrial cancer: a population-based case–control study in Shanghai, China. Nutr Cancer 62: 40-50, 2010.
    OpenUrlPubMed
  93. ↵
    1. Bastide NM,
    2. Pierre FH,
    3. Corpet DE
    : Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila) 4: 177-184, 2011.
    OpenUrlAbstract/FREE Full Text
  94. ↵
    1. Sliwinski T,
    2. Czechowska A,
    3. Kolodziejczak M,
    4. Jajte J,
    5. Wisniewska-Jarosinska M,
    6. Blasiak J
    : Zinc salts differentially modulate DNA damage in normal and cancer cells. Cell Biol Int 33: 542-547, 2009.
    OpenUrlCrossRefPubMed
  95. ↵
    1. Jakszyn P,
    2. González CA,
    3. Luján-Barroso L,
    4. Ros MM,
    5. Bueno-de-Mesquita HB,
    6. Roswall N,
    7. Tjønneland AM,
    8. Büchner FL,
    9. Egevad L,
    10. Overvad K,
    11. Raaschou-Nielsen O,
    12. Clavel-Chapelon F,
    13. Boutron-Ruault MC,
    14. Touillaud MS,
    15. Chang-Claude J,
    16. Allen NE,
    17. Kiemeney LA,
    18. Key TJ,
    19. Kaaks R,
    20. Boeing H,
    21. Weikert S,
    22. Trichopoulou A,
    23. Oikonomou E,
    24. Zylis D,
    25. Palli D,
    26. Berrino F,
    27. Vineis P,
    28. Tumino R,
    29. Mattiello A,
    30. Peeters PH,
    31. Parr CL,
    32. Gram IT,
    33. Skeie G,
    34. Sánchez MJ,
    35. Larrañaga N,
    36. Ardanaz E,
    37. Navarro C,
    38. Rodríguez L,
    39. Ulmert D,
    40. Ehrnström R,
    41. Hallmans G,
    42. Ljungberg B,
    43. Roddam AW,
    44. Bingham SA,
    45. Khaw KT,
    46. Slimani N,
    47. Boffetta PA,
    48. Jenab M,
    49. Mouw T,
    50. Michaud DS,
    51. Riboli E
    : Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 20: 555-559, 2011.
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. Grant WB
    : Air pollution in relation to U.S. cancer mortality rates: An ecological study; likely role of carbonaceous aerosols and polycyclic aromatic hydrocarbons. Anticancer Res 29: 3537-3545, 2009.
    OpenUrlAbstract/FREE Full Text
  97. ↵
    1. Lewtas J
    : Air pollution combustion emissions: characterization of causative agents and mechanisms associated with cancer, reproductive, and cardiovascular effects. Mutat Res 636: 95-133, 2007.
    OpenUrlPubMed
  98. ↵
    1. Pope CA 3rd.,
    2. Burnett RT,
    3. Turner MC,
    4. Cohen AJ,
    5. Krewski D,
    6. Jerrett M,
    7. Gapstur SM,
    8. Thun MJ
    : Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: Shape of the exposure-response relationships. Environ Health Perspect. 2011 Jul 19. [Epub ahead of print].
  99. ↵
    1. Grant WB
    : How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermato-Endocrinology 1: 17-24, 2009.
    OpenUrlCrossRef
  100. ↵
    1. Abnet CC,
    2. Chen W,
    3. Dawsey SM,
    4. Wei WQ,
    5. Roth MJ,
    6. Lie B,
    7. Lu N,
    8. Taylor PR,
    9. Qiao YL
    : Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16: 1889-1893, 2007.
    OpenUrlAbstract/FREE Full Text
  101. ↵
    1. Ross AC,
    2. Manson JE,
    3. Abrams SA,
    4. Aloia JF,
    5. Brannon PM,
    6. Clinton SK,
    7. Durazo-Arvizu RA,
    8. Gallagher JC,
    9. Gallo RL,
    10. Jones G,
    11. Kovacs CS,
    12. Mayne ST,
    13. Rosen CJ,
    14. Shapses SA
    : The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58, 2011.
    OpenUrlCrossRefPubMed
  102. ↵
    1. Lappe JM,
    2. Travers-Gustafson D,
    3. Davies KM,
    4. Recker RR,
    5. Heaney RP
    : Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591, 2007.
    OpenUrlAbstract/FREE Full Text
  103. ↵
    1. Garland CF,
    2. French CB,
    3. Baggerly LL,
    4. Heaney RP
    : Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 31: 617-622, 2011.
    OpenUrl
  104. ↵
    1. Grant WB
    : An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 65: 1016-1026, 2011.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 32 (1)
Anticancer Research
Vol. 32, Issue 1
January 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ecological Studies of the UVB–Vitamin D–Cancer Hypothesis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ecological Studies of the UVB–Vitamin D–Cancer Hypothesis
WILLIAM B. GRANT
Anticancer Research Jan 2012, 32 (1) 223-236;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ecological Studies of the UVB–Vitamin D–Cancer Hypothesis
WILLIAM B. GRANT
Anticancer Research Jan 2012, 32 (1) 223-236;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Summary and Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort
  • Vitamin D in schizophrenia: a clinical review
  • 25-Hydroxyvitamin D and Breast Cancer, Colorectal Cancer, and Colorectal Adenomas: Case-Control versus Nested Case-Control Studies
  • Pharyngeal and Cervical Cancer Incidences Significantly Correlate with Personal UV Doses Among Whites in the United States
  • Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data
  • Serum Vitamin D and Risk of Bladder Cancer in PLCO-Letter
  • Google Scholar

More in this TOC Section

  • The Difference between 14-Epi-previtamin D3 and 14-Epi-19-norprevitamin D3: Their Synthesis and Binding Affinity for Human VDR
  • The Scots' Paradox: Can Sun Exposure, or Lack of it, Explain Major Paradoxes in Epidemiology?
  • Optimal Serum Calcidiol Concentration for Cancer Prevention
Show more Proceedings of the 4th International Symposium on Vitamin D and Analogs in Cancer Prevention and Therapy, May 20-21, 2011, Homburg/Saar, Germany

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire